Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Single Arm, Single Center Phase IV Clinical Trial to Evaluate the Immune Persistence and Safety of Freeze-dried Human Rabies Vaccine (Vero Cell)

Authors not listed

Changchun Zhuoyi Biological Co., Ltd · 2019

Abstract

Evaluation of immune persistence after rabies vaccination in 150 people.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-19 MST

Cite this

APA
Anonymous. (2019). Single Arm, Single Center Phase IV Clinical Trial to Evaluate the Immune Persistence and Safety of Freeze-dried Human Rabies Vaccine (Vero Cell). <em>Changchun Zhuoyi Biological Co., Ltd</em>. https://clinicaltrials.gov/study/NCT05547815
Vancouver
Anonymous. Single Arm, Single Center Phase IV Clinical Trial to Evaluate the Immune Persistence and Safety of Freeze-dried Human Rabies Vaccine (Vero Cell). Changchun Zhuoyi Biological Co., Ltd. 2019.
BibTeX
@misc{anon2019Single, title = {Single Arm, Single Center Phase IV Clinical Trial to Evaluate the Immune Persistence and Safety of Freeze-dried Human Rabies Vaccine (Vero Cell)}, author = {Anonymous}, journal = {Changchun Zhuoyi Biological Co., Ltd}, year = {2019}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings